PRME

Prime Medicine (PRME)

About Prime Medicine (PRME)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$6.94
52 Week Low
$1.40
Market cap
520.2M
Dividend yield
0.00%
Volume
4,387
Avg. volume
2.9M
P/E ratio
-2.30

Prime Medicine News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$6.94
52 Week Low
$1.40
Market cap
520.2M
Dividend yield
0.00%
Volume
4,387
Avg. volume
2.9M
P/E ratio
-2.30